Tumor volume change after chemotherapy as a predictive factor of disease free survival for osteosarcoma

Seong Hwan Moon, Kyoo Ho Shin, Jin Suck Suh, Woo Ick Yang, Jae Keong Noh, Soo Bong Hahn

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Change in tumor volume after chemotherapy appears to have a prognostic significance for the outcome of osteosarcoma. A newly developed volume measurement method based on three-dimensional summation with a proved reproducibility was utilized to measure osteosarcoma tumor volume. This retrospective analysis included 38 patients with biopsy-proven, nonsurface, skeletal high-grade osteosarcoma. The treatment was started by using three cycles of preoperative chemotherapy with cisplastin (100 mg/m2) and adriamycin (30 mg/m2). The tumor volume was measured before and after preoperative chemotherapy using three-dimensional magnetic resonance image measurement. The percentage of tumor necrosis was assessed by pathologic exam. After three cycle of postoperative chemotherapy, the patients were followed up at regular interval. For the 23 good responder patients, the mean survival time was 73.2 months (95% confidence interval 61.9-84.5 months), and for the 15 poor responder patients, the mean survival time was 50.8 months (95% confidence interval 38.6-63.1 months) (p<0.05). For the 14 patients with increased tumor volume after chemotherapy, the mean survival time was 47.5 months (range: 36.3-58.6 months) and for the 24 patients with stable or decreased tumor volume, the mean survival time was 74.3 months (range: 63.79-84.88 months) (p<0.05). Among the various factors, histopathologic response and tumor volume change after chemotherapy predicted disease free survival (p<0.05). Change in the tumor volume that was measured with a reproducible method and the histopathologic response after chemotherapy were the important predictors of disease free survival for osteosarcoma patients.

Original languageEnglish
Pages (from-to)119-124
Number of pages6
JournalYonsei medical journal
Volume46
Issue number1
DOIs
Publication statusPublished - 2005 Feb 28

Fingerprint

Osteosarcoma
Tumor Burden
Disease-Free Survival
Drug Therapy
Survival Rate
Confidence Intervals
Doxorubicin
Necrosis
Magnetic Resonance Spectroscopy
Biopsy
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Moon, Seong Hwan ; Shin, Kyoo Ho ; Suh, Jin Suck ; Yang, Woo Ick ; Noh, Jae Keong ; Hahn, Soo Bong. / Tumor volume change after chemotherapy as a predictive factor of disease free survival for osteosarcoma. In: Yonsei medical journal. 2005 ; Vol. 46, No. 1. pp. 119-124.
@article{ea411cbf34954e02a3d292b8351852d5,
title = "Tumor volume change after chemotherapy as a predictive factor of disease free survival for osteosarcoma",
abstract = "Change in tumor volume after chemotherapy appears to have a prognostic significance for the outcome of osteosarcoma. A newly developed volume measurement method based on three-dimensional summation with a proved reproducibility was utilized to measure osteosarcoma tumor volume. This retrospective analysis included 38 patients with biopsy-proven, nonsurface, skeletal high-grade osteosarcoma. The treatment was started by using three cycles of preoperative chemotherapy with cisplastin (100 mg/m2) and adriamycin (30 mg/m2). The tumor volume was measured before and after preoperative chemotherapy using three-dimensional magnetic resonance image measurement. The percentage of tumor necrosis was assessed by pathologic exam. After three cycle of postoperative chemotherapy, the patients were followed up at regular interval. For the 23 good responder patients, the mean survival time was 73.2 months (95{\%} confidence interval 61.9-84.5 months), and for the 15 poor responder patients, the mean survival time was 50.8 months (95{\%} confidence interval 38.6-63.1 months) (p<0.05). For the 14 patients with increased tumor volume after chemotherapy, the mean survival time was 47.5 months (range: 36.3-58.6 months) and for the 24 patients with stable or decreased tumor volume, the mean survival time was 74.3 months (range: 63.79-84.88 months) (p<0.05). Among the various factors, histopathologic response and tumor volume change after chemotherapy predicted disease free survival (p<0.05). Change in the tumor volume that was measured with a reproducible method and the histopathologic response after chemotherapy were the important predictors of disease free survival for osteosarcoma patients.",
author = "Moon, {Seong Hwan} and Shin, {Kyoo Ho} and Suh, {Jin Suck} and Yang, {Woo Ick} and Noh, {Jae Keong} and Hahn, {Soo Bong}",
year = "2005",
month = "2",
day = "28",
doi = "10.3349/ymj.2005.46.1.119",
language = "English",
volume = "46",
pages = "119--124",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "1",

}

Tumor volume change after chemotherapy as a predictive factor of disease free survival for osteosarcoma. / Moon, Seong Hwan; Shin, Kyoo Ho; Suh, Jin Suck; Yang, Woo Ick; Noh, Jae Keong; Hahn, Soo Bong.

In: Yonsei medical journal, Vol. 46, No. 1, 28.02.2005, p. 119-124.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tumor volume change after chemotherapy as a predictive factor of disease free survival for osteosarcoma

AU - Moon, Seong Hwan

AU - Shin, Kyoo Ho

AU - Suh, Jin Suck

AU - Yang, Woo Ick

AU - Noh, Jae Keong

AU - Hahn, Soo Bong

PY - 2005/2/28

Y1 - 2005/2/28

N2 - Change in tumor volume after chemotherapy appears to have a prognostic significance for the outcome of osteosarcoma. A newly developed volume measurement method based on three-dimensional summation with a proved reproducibility was utilized to measure osteosarcoma tumor volume. This retrospective analysis included 38 patients with biopsy-proven, nonsurface, skeletal high-grade osteosarcoma. The treatment was started by using three cycles of preoperative chemotherapy with cisplastin (100 mg/m2) and adriamycin (30 mg/m2). The tumor volume was measured before and after preoperative chemotherapy using three-dimensional magnetic resonance image measurement. The percentage of tumor necrosis was assessed by pathologic exam. After three cycle of postoperative chemotherapy, the patients were followed up at regular interval. For the 23 good responder patients, the mean survival time was 73.2 months (95% confidence interval 61.9-84.5 months), and for the 15 poor responder patients, the mean survival time was 50.8 months (95% confidence interval 38.6-63.1 months) (p<0.05). For the 14 patients with increased tumor volume after chemotherapy, the mean survival time was 47.5 months (range: 36.3-58.6 months) and for the 24 patients with stable or decreased tumor volume, the mean survival time was 74.3 months (range: 63.79-84.88 months) (p<0.05). Among the various factors, histopathologic response and tumor volume change after chemotherapy predicted disease free survival (p<0.05). Change in the tumor volume that was measured with a reproducible method and the histopathologic response after chemotherapy were the important predictors of disease free survival for osteosarcoma patients.

AB - Change in tumor volume after chemotherapy appears to have a prognostic significance for the outcome of osteosarcoma. A newly developed volume measurement method based on three-dimensional summation with a proved reproducibility was utilized to measure osteosarcoma tumor volume. This retrospective analysis included 38 patients with biopsy-proven, nonsurface, skeletal high-grade osteosarcoma. The treatment was started by using three cycles of preoperative chemotherapy with cisplastin (100 mg/m2) and adriamycin (30 mg/m2). The tumor volume was measured before and after preoperative chemotherapy using three-dimensional magnetic resonance image measurement. The percentage of tumor necrosis was assessed by pathologic exam. After three cycle of postoperative chemotherapy, the patients were followed up at regular interval. For the 23 good responder patients, the mean survival time was 73.2 months (95% confidence interval 61.9-84.5 months), and for the 15 poor responder patients, the mean survival time was 50.8 months (95% confidence interval 38.6-63.1 months) (p<0.05). For the 14 patients with increased tumor volume after chemotherapy, the mean survival time was 47.5 months (range: 36.3-58.6 months) and for the 24 patients with stable or decreased tumor volume, the mean survival time was 74.3 months (range: 63.79-84.88 months) (p<0.05). Among the various factors, histopathologic response and tumor volume change after chemotherapy predicted disease free survival (p<0.05). Change in the tumor volume that was measured with a reproducible method and the histopathologic response after chemotherapy were the important predictors of disease free survival for osteosarcoma patients.

UR - http://www.scopus.com/inward/record.url?scp=14944368255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944368255&partnerID=8YFLogxK

U2 - 10.3349/ymj.2005.46.1.119

DO - 10.3349/ymj.2005.46.1.119

M3 - Article

C2 - 15744814

AN - SCOPUS:14944368255

VL - 46

SP - 119

EP - 124

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 1

ER -